Keenova Reports First Quarter 2026 Financial Results May 12, 2026 06:30AM
Keenova Announces Unaudited Fourth Quarter 2025 Financial Results Mar 31, 2026 06:30AM
Keenova Publishes XIAFLEX® (collagenase clostridium histolyticum) Analysis in Journal of Hand Surgery Global Online Mar 3, 2026 07:30AM
Keenova presents plantar fibromatosis clinical data at ACFAS meeting Feb 24, 2026 07:30AM
Keenova Unveils Clinical Data from Phase 2 Plantar Fibromatosis Study at the ACFAS Annual Meeting Feb 24, 2026 07:30AM


Feb 16, 2026 07:30AM Keenova Announces New Manuscript on Plantar Fibromatosis Treatment Patterns in Peer-Reviewed Journal of Foot and Ankle Surgery
Jan 21, 2026 07:30AM Keenova Marks 100K Peyronie's Disease Patients--a Major Milestone for an Often-Stigmatized Men's Health Condition
Jan 13, 2026 04:47PM Keenova presents Dupuytren's contracture survey at hand surgery meeting
Jan 13, 2026 04:45PM Keenova Announces New Dupuytren's Contracture Survey Presentation About Patient Perceptions and Treatment Outcomes
Nov 10, 2025 07:00AM Mallinckrodt Reports Third Quarter 2025 Financial Results
Nov 10, 2025 06:30AM Mallinckrodt completes Par Health spin-off, rebrands as Keenova Therapeutics
Nov 10, 2025 06:30AM Mallinckrodt Completes Spin-Off of Par Health, Introduces Keenova Therapeutics
Aug 6, 2025 06:30AM Mallinckrodt plc Reports Financial Results for Second Quarter 2025 and Provides Guidance
Aug 1, 2025 07:00AM Mallinckrodt completes merger with Endo to form combined therapeutics company
Aug 1, 2025 07:00AM Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader
Jun 9, 2025 08:33AM Mallinckrodt (MNK) and Endo (NDOI) Announce Planned Leadership Team for Merged Company
Jun 9, 2025 08:30AM Mallinckrodt, Endo Announce Planned Leadership Team for Merged Company
May 13, 2025 08:00AM Mallinckrodt and Endo Announce Significant Progress in Proposed Merger
May 6, 2025 06:45AM Mallinckrodt plc Reports First Quarter 2025 Financial Results and Reaffirms Full-Year Guidance
Mar 13, 2025 06:31AM Mallinckrodt (MNK) and Endo (NDOI) to Combine
Mar 13, 2025 06:31AM Mallinckrodt plc Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides 2025 Guidance
Mar 13, 2025 06:30AM Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
May 30, 2017 04:17PM Exclusive: Mallinckrodt explores sale of generic drugs business - sources
Jan 18, 2017 04:55PM Mallinckrodt to pay $100 million to settle U.S. probe on drug pricing
Nov 9, 2016 04:27AM Pharma, biotech shares soar as Trump win calms pricing talk
Sep 15, 2016 08:31AM Drug Stocks on Watch as Bipartisian Bill Expected on Capping Price Increases
Sep 2, 2016 09:43AM Mylan (MYL), Valeant (VRX), Related Stocks Pressured Following Market Open
Apr 14, 2016 12:07PM Leerink Highlights Top 10 Biopharma Stocks for Partnerships & Acquisitions
Mar 23, 2016 06:44AM Guggenheim Defends Mallinckrodt (MNK)
Nov 19, 2015 09:00AM Mallinckrodt plc Board Adds $500 Million To Company's Existing Share Repurchase Program
Nov 16, 2015 07:30AM Mallinckrodt Pharmaceuticals Receives FDA Clearance For INOmax DS(IR)® Plus MRI Device
Nov 10, 2015 07:24AM Stressed Mallinckrodt (MNK) SOTP Suggests $70-$90/Share, Jefferies Says
Oct 30, 2015 06:35AM Mallinckrodt's INOmax® Approved In Australia And Japan For Pulmonary Hypertension In Conjunction With Heart Surgery
Oct 23, 2015 01:21AM Valeant's looming M&A hiatus deals blow to investment banks
Oct 21, 2015 12:39PM Mizuho Weighs in on Panic in Specialty Pharmaceuticals Sector (VRX) (AGN) (ENDP) (SCMP) (JAZZ) (MNK)
Oct 6, 2015 06:00AM Mallinckrodt plc Provides Business Update Including Fiscal Year 2016 Financial Guidance Excluding Contrast Media and Delivery Systems (CMDS) and Ex-CMDS Historical Financial Information
Sep 28, 2015 06:45AM Mallinckrodt Completes Acquisition Of Therakos, Inc.
Sep 9, 2015 08:42AM Mallinckrodt Launches Notes Offering
Aug 10, 2015 05:00AM Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Acquisition Of Therakos, Inc.
Aug 4, 2015 06:55AM Mallinckrodt plc Reports Fiscal 2015 Third Quarter Financial Results
Jul 27, 2015 05:55PM Mallinckrodt Enters Agreement To Sell Its Contrast Media And Delivery Systems Imaging Business To Guerbet For $270 Million
May 5, 2015 06:55AM Mallinckrodt plc Reports Fiscal 2015 Second Quarter Financial Results; Raises Full Year 2015 Guidance
Apr 16, 2015 04:15PM Mallinckrodt Completes Acquisition Of Ikaria
Apr 6, 2015 08:30AM Mallinckrodt Launches Notes Offering
Mar 5, 2015 07:00AM Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition
Apr 9, 2014 10:58AM UPDATE: UBS Upgrades Mallinckrodt (MNK) to Buy
Mar 14, 2014 06:45AM Mallinckrodt plc (MNK) Target Lifted to $77 at Jefferies